The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients

Sozeri, B.; Sonmez, H.; Karadag, S.; Baglan, E.; Ozturk, K.; Cakan, M.; Demir, F.; Yener, G.; Ozdel, S.; Ayaz, N.

The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients

Atıf İçin Kopyala

Sozeri B., Sonmez H. E., Karadag S. G., Baglan E., Ozturk K., Cakan M., ...Daha Fazla

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.39, sa.5, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 39 Sayı: 5
Basım Tarihi: 2021
Dergi Adı: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
Anahtar Kelimeler: canakinumab, colchicine resistance, familial Mediterranean fever, CHILDREN
İstanbul Üniversitesi Adresli: Hayır

Özet

Objective. To determine the feasibility of withdrawing canakinumab (CAN) in a large cohort of paediatric patients with colchicine-resistant familial Mediterranean fever (crFMF).